Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories 2024-03-01 21:35
1